1,755 Shares in Synopsys, Inc. $SNPS Acquired by Magnolia Capital Advisors LLC

Magnolia Capital Advisors LLC bought a new stake in shares of Synopsys, Inc. (NASDAQ:SNPSFree Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 1,755 shares of the semiconductor company’s stock, valued at approximately $783,000.

Several other large investors have also recently made changes to their positions in the stock. Sankala Group LLC purchased a new stake in Synopsys in the fourth quarter valued at approximately $25,000. Elevation Wealth Partners LLC raised its position in Synopsys by 96.4% during the 2nd quarter. Elevation Wealth Partners LLC now owns 55 shares of the semiconductor company’s stock worth $25,000 after buying an additional 27 shares during the last quarter. Osbon Capital Management LLC purchased a new position in Synopsys during the 2nd quarter worth approximately $25,000. Caitong International Asset Management Co. Ltd acquired a new stake in Synopsys during the 4th quarter valued at approximately $28,000. Finally, IMG Wealth Management Inc. purchased a new stake in shares of Synopsys in the 2nd quarter valued at $28,000. 85.47% of the stock is owned by institutional investors.

Synopsys Trading Up 0.3%

Shares of Synopsys stock opened at $410.00 on Thursday. The firm has a 50-day simple moving average of $416.71 and a two-hundred day simple moving average of $439.84. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.32 and a current ratio of 1.43. Synopsys, Inc. has a fifty-two week low of $366.00 and a fifty-two week high of $615.79. The company has a market cap of $78.51 billion, a P/E ratio of 94.91, a price-to-earnings-growth ratio of 2.40 and a beta of 1.23.

Synopsys (NASDAQ:SNPSGet Free Report) last announced its quarterly earnings results on Wednesday, August 26th. The semiconductor company reported $3.91 earnings per share for the quarter, beating the consensus estimate of $3.67 by $0.24. The firm had revenue of $2.48 billion during the quarter, compared to analyst estimates of $2.44 billion. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.Synopsys’s revenue for the quarter was up 42.4% compared to the same quarter last year. During the same quarter in the previous year, the business earned $3.39 EPS. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. As a group, equities analysts predict that Synopsys, Inc. will post 10.64 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, CEO Sassine Ghazi sold 14,603 shares of Synopsys stock in a transaction on Monday, June 15th. The shares were sold at an average price of $458.96, for a total value of $6,702,192.88. Following the sale, the chief executive officer owned 75,020 shares of the company’s stock, valued at approximately $34,431,179.20. This trade represents a 16.29% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Shelagh Glaser sold 3,394 shares of the business’s stock in a transaction on Friday, June 12th. The stock was sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the completion of the sale, the chief financial officer directly owned 14,358 shares of the company’s stock, valued at approximately $6,461,387.16. The trade was a 19.12% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.56% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

A number of research firms have recently weighed in on SNPS. Needham & Company LLC reiterated a “buy” rating and issued a $580.00 price objective on shares of Synopsys in a research note on Thursday, May 28th. Rosenblatt Securities reaffirmed a “buy” rating and issued a $575.00 price target on shares of Synopsys in a report on Tuesday. BNP Paribas Exane increased their price target on Synopsys from $425.00 to $450.00 and gave the stock an “underperform” rating in a research report on Thursday, May 28th. Stifel Nicolaus lifted their price objective on Synopsys from $550.00 to $600.00 and gave the company a “buy” rating in a research note on Thursday, May 28th. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of Synopsys in a report on Monday, June 8th. Eleven analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $563.59.

Get Our Latest Analysis on SNPS

Trending Headlines about Synopsys

Here are the key news stories impacting Synopsys this week:

  • Positive Sentiment: Synopsys reported fiscal Q3 revenue of $2.477 billion, up 42.4% year over year, while non-GAAP EPS of $3.91 exceeded the $3.67 consensus estimate. Design Automation was the primary contributor, indicating broad demand for chip-design software. Synopsys Posts Financial Results for Third Quarter Fiscal Year 2026
  • Positive Sentiment: Management raised its fiscal 2026 outlook to approximately $9.715 billion in revenue and $15.07 in non-GAAP EPS at the midpoints. The company also projected fourth-quarter EPS of $4.10-$4.16, above the $3.78 analyst consensus, citing continued AI-driven demand and benefits from the Ansys business. Synopsys raises annual forecasts on AI-driven chip design software demand
  • Positive Sentiment: Synopsys continues to position AI as a growth driver, saying customers are achieving substantial productivity gains and that engineering workflows are moving toward more autonomous systems. Nvidia’s reported $2 billion investment in Synopsys also reinforces the strategic importance of AI-powered design and simulation. Nvidia’s $2 Billion Synopsys Bet Signals AI’s Next Frontier
  • Neutral Sentiment: Analyst sentiment remains favorable: Rosenblatt reaffirmed a Buy rating and set a $575 price target. However, SNPS trades at a high earnings multiple, leaving the shares sensitive to guidance, execution and valuation concerns. Rosenblatt Reiterates Buy Rating on Synopsys
  • Negative Sentiment: The stock declined even after the earnings beat and guidance increase. The reaction indicates that strong results may already have been priced in, while full-year revenue guidance was broadly aligned with expectations and fourth-quarter revenue guidance of $2.53-$2.58 billion did not clearly exceed consensus. Synopsys slides even as it boosts full-year guidance

Synopsys Profile

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front?end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape?out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

See Also

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPSFree Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.